We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Electroporation Technique May Prevent Restenosis

By HospiMedica International staff writers
Posted on 17 Mar 2009
In a recent study, investigators described the use of a novel tissue ablation method that kills cells by inducing selective damage only to the cell membrane while sparing all other tissue components. More...
This method shows promise for the prevention of restenosis, the reblockage of an artery that had been opened by angioplasty.

The technique, called NTIRE (nonthermal irreversible electroporation), destroys cells within seconds, using very short electric field pulses. The treatment causes no damage to extracellular tissues or structures.

Investigators from the Hebrew University of Jerusalem (Israel) used a group of 33 Sprague-Dawley rats to optimize the NTIRE protocol. Each animal had NTIRE applied to its left common carotid artery using custom-made electrodes that supplied electric pulses of 100 microseconds. The right carotid artery was used as control.

Results published in the March 9, 2009, online edition of the journal PLoS ONE revealed that the most efficient protocols were 10 pulses of 3500 V/cm at a frequency of 10 Hz and 90 pulses of 1750 V/cm at a frequency of 1 Hz, with ablation efficiency of 89 ± 16% and 94 ± 9%, respectively. Extra-cellular structures were not damaged and the endothelial layer recovered completely.

Based on their promising results the authors concluded that, "NTIRE is a promising, efficient and simple novel technology for vascular smooth muscle cell [VMSC] ablation. It enables ablation within seconds without causing damage to extracellular structures, thus preserving the arterial scaffold and enabling endothelial regeneration. This study provides scientific information for future anti-restenosis experiments utilizing NTIRE.”

Related Links:

Hebrew University of Jerusalem



Gold Member
Handheld Blood Glucose Analyzer
STAT-Site
Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Blood Pressure Monitor
Cuff Blood Pressure Monitor
Hybrid Arch Device
Neo EDE
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: The device is worn on a finger and measures blood pressure without an arm‑compressing cuff (Photo courtesy of Sky Labs)

Ring-Type Cuffless Monitor Becomes First Added to Official Hypertension Guidelines

Detecting nocturnal and morning hypertension often requires out-of-office assessment, but conventional cuff-type monitors can disrupt sleep. New national guidance in South Korea expands 24-hour monitoring... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.